Imidazole Derivative Synthesis via Ultrasonic Ionic Liquid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, particularly bacteria and fungi, as conventional antibiotics face increasing resistance, and existing methods for synthesizing organic compounds often involve hazardous solvents and inefficient processes.
Innovation Solution
The synthesis of 5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid via a one-pot four-component reaction using Pyridinium Ionic Liquid as a catalyst and solvent, combined with ultrasonic irradiation, to produce a compound with demonstrated antimicrobial activity against various gram-positive and gram-negative bacteria, as well as fungi.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections, then existing treatments can address common infections, but increasing drug resistance reduces their effectiveness
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of imidazole derivatives through systematic variation of substituents at different positions (R1-R6 groups). This structural parameter modification generates novel compounds with improved antimicrobial activity against drug-resistant strains, effectively addressing the resistance problem by changing the molecular parameters rather than using existing antibiotics
Solution Approach 2:
The invention creates composite molecular structures by combining imidazole core with various aromatic substituents (chlorophenyl, thiazolyl, pyrimidinyl groups) and side chains. These composite structures integrate multiple functional groups that work synergistically to achieve enhanced antimicrobial activity and overcome drug resistance mechanisms
2Ease of manufacture
If traditional synthesis methods are used for organic compounds, then conventional procedures can produce compounds, but hazardous solvents and inefficient processes increase environmental impact
Solution Approach 1:
The patent replaces traditional thermal heating methods with ultrasonic irradiation (sonication) to drive the condensation reaction. This substitution of the energy input mechanism enables the reaction to proceed under milder conditions, reduces energy consumption, and eliminates the need for hazardous solvents while maintaining high yields and purity
Solution Approach 2:
The invention changes the physical parameters of the reaction system by using ultrasonic frequency (20 kHz) and reduced temperature (room temperature to 60°C) compared to conventional high-temperature heating. These parameter changes enable green chemistry synthesis without compromising reaction efficiency or product quality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound exhibits excellent antimicrobial activity against Bacillus cereus, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Aspergillus flavus, and Chrysosporium keratinophilum, offering a promising therapeutic option for microbial infections while employing a greener, more efficient synthesis method.
Implementation Method 1
The synthesis of 5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid via one-pot four-component reaction of 1,2-bis(4-chlorophenyl)ethane-1,2-dione (I), 4-chlorobenzaldehyde (II), 5-aminopentanoic acid (III) and ammonium acetate (IV) in Pyridinium Ionic Liquid as a catalyst and green solvent. Also, we used ultrasonic technique as a source of heat as an eco-friendly method
Data Source
AI summary
An 5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid compound, its synthesis, and its use as an antimicrobial agent.